Dow Jones lost 178 points, dragged by the reduced profit expectations of the main health companies in the United States.
Stock markets are gathering thanks to the decallation of the China-United States rate, but Dow Jones is still lagging behind. On Tuesday, May 13, the S&P 500 was at 5,893 points, an increase of 50 points or 0.85%, entering positive territory for the year of 2025. The Nasdaq centered on technology was quoted at 21,222.80, more than 354,652 points or 1.7%.
At the same time, Dow Jones was at 42,250.67 points, less than 159.43 or 0.38%. This despite the fact that positive developments in US-China commercial relations increased technological actions. For example, Nvidia rose 5.79%, Amazon increased by 1.64%, while IBM gained 1.87%.
Medical care actions hammered by Trump’s new movement
Even so, Nvidia and Amazon profits were overcome by the loss of Microsoft of 0.28%, as well as the significant losses of medical care companies. For example, Johnson and Johnson lost 3.04%, while Merck lost 3.18%, both companies involved in medical care.
What’s more, Unitedhealth lost a surprising 16.34% after a Abrupt output For a long time, Andrew Witty. The company also suspended its annual price prognosis, citing the increase in medical costs for the decision.
Medical care actions have been declined after the president of the United States, Donald Trump, signed an executive order aimed at reducing the prices of prescription medications. The administration ordered companies that reduce medicines prices at levels similar to what patients in other countries are paying. For those who do not comply, the White House has threatened intense but not specified measures to keep them online.
Estimated analysts Than to reduce the prices of medicines in the US. UU. It could reduce 2028 net income for the world pharmaceutical industry by 8%. Even so, although the measure would reduce the profits of medical care companies, it could generate relief to Americans fighting for the increase in medical care costs.
